re:sirtex and hunter hall Huner hall is going to report again soon that they are increasing position again. Then Dr Gray and Huner hallalong with a couple of insitutions will be announcing they have the shares and votes to sell the company to the highest bidder. There are several acquisitions now in bio-pharma and the most likely suitors are Cephalon which previously bid $4.75 in 2003 which was rejected as too low of an offer, Roche-Xeloda, Sanofi and Pfizer with oxaliplatin and Irinotecan, and Genetech with Avastin all of which have work synergisically with Sir spheres to double survival times in many cases fro metastaic disease to the liver. Nat Geissel in the USA is leading the rapid growth and acceptance of Sir Spheres to off-label usage of Sir Spheres which is leading to rapid growth of the company. Huner hall is going to keep buying and make a very handsome profit for their clients by the Holidayslike 200-300%. My opinion only after being in the industry a long time . do your own work.
Add to My Watchlist
What is My Watchlist?